Reliant Glycosciences is a biotechnology company focused on developing diagnostic and prognostic tools for patients with IgA nephropathy.
Reliant Glycosciences's investors include National Institutes of Health, Innovate Alabama.
Reliant Glycosciences is headquartered in Birmingham, United States.
Reliant Glycosciences is a biotechnology company focused on developing diagnostic and prognostic tools for patients with IgA nephropathy.
Reliant Glycosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reliant Glycosciences — Funding & Investors." VCBacked, August 29, 2022, https://www.vcbacked.co/company/reliant-glycosciences. Accessed October 31, 2026.
VCBacked. (2022). Reliant Glycosciences — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/reliant-glycosciences
{{cite web |title=Reliant Glycosciences — Funding & Investors |url=https://www.vcbacked.co/company/reliant-glycosciences |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated